Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Fresenius Medical Care AG & Co. KGaA

Healthcare US FMCQF

45.17USD
0.00(0%)

Last update at 2026-06-18T20:00:00Z

Day Range

43.0143.08
LowHigh

52 Week Range

44.2560.07
LowHigh

Fundamentals

  • Previous Close 45.17
  • Market Cap15299.52M
  • Volume2000
  • P/E Ratio14.21
  • Dividend Yield3.31%
  • EBITDA2622.43M
  • Revenue TTM19627.60M
  • Revenue Per Share TTM67.41
  • Gross Profit TTM 5028.93M
  • Diluted EPS TTM3.94

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1511.43M 1056.93M 1033.02M 1220.00M 1572.00M
Minority interest -212.90000M -202.95700M -233.46100M -222.00000M -250.00000M
Net income 977.63M 537.91M 499.00M 673.00M 969.00M
Selling general administrative 3032.73M 2366.29M 2388.38M 3784.00M 3096.00M
Selling and marketing expenses - 776.53M 807.96M - -
Gross profit 5027.12M 4756.65M 4925.01M 5310.00M 5077.00M
Reconciled depreciation 1500.41M 1742.26M 1751.97M 1838.36M 1623.68M
Ebit 1896.29M 1463.97M 1457.65M 1576.10M 1845.85M
Ebitda 3395.73M 3206.23M 3209.63M 1580.00M 1925.00M
Depreciation and amortization 1499.44M 1742.26M 1751.97M - -
Non operating income net other - - - - -
Operating income 1837.31M 1392.39M 1369.44M 1297.00M 1760.00M
Other operating expenses 17783.34M 17943.51M 18084.18M - -
Interest expense 384.86M 407.04M 424.64M 360.00M 353.60M
Tax provision 320.97M 316.06M 300.56M 325.00M 353.00M
Interest income 69.61M 71.58M 88.22M 68.00M 73.00M
Net interest income -314.79800M -335.46900M -336.42300M -292.00000M -280.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 320.88M 316.06M 300.56M 324.95M 352.83M
Total revenue 19620.65M 19335.91M 19453.62M 19398.00M 17619.00M
Total operating expenses 3189.80M 3364.26M 3555.57M 18101.00M 15859.00M
Cost of revenue 14593.53M 14579.26M 14528.61M 14088.00M 12542.00M
Total other income expense net -325.87790M -335.46900M -336.42300M 215.00M 92.00M
Discontinued operations - - - - -
Net income from continuing ops 1191.27M 740.87M 732.46M 895.00M 1219.00M
Net income applicable to common shares - - - 673.40M 969.31M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 30990.39M 33566.58M 33929.81M 35754.00M 34367.00M
Intangible assets 1254.02M 1370.08M 1362.33M 1518.68M 1459.39M
Earning assets - - - - -
Other current assets 888.02M 487.38M 1326.39M 370.83M 346.31M
Total liab 16712.74M 17798.07M 19103.27M 20305.00M 20388.00M
Total stockholder equity 13304.85M 14576.56M 13620.26M 15449.00M 13979.00M
Deferred long term liab - - - - -
Other current liab 3308.43M 3092.67M 3370.28M 2329.67M 2552.96M
Common stock 293.30M 293.41M 293.41M 293.41M 293.00M
Capital stock 293.41M 293.41M 293.41M 293.41M 293.00M
Retained earnings 12203.34M 11266.29M 10921.69M 10711.71M 10826.14M
Other liab - - - 2661.95M 2395.14M
Good will 13566.31M 15170.65M 14650.01M 15791.18M 14361.58M
Other assets - - -0.00000M 1127.27M 1239.97M
Cash 1598.40M 1150.95M 1377.03M 1273.79M 1481.65M
Cash and equivalents - - - - -
Total current liabilities 6242.66M 5660.06M 6111.59M 6467.31M 7257.63M
Current deferred revenue - 82.17M 85.82M - -
Net debt 12098.49M 9827.96M 10673.39M 7260.02M 8571.00M
Short term debt 2196.51M 1218.27M 1561.56M - -
Short long term debt 1613.04M 577.38M 944.60M 1363.08M 1924.00M
Short long term debt total 13696.89M 10978.91M 12050.41M - -
Other stockholder equity 2492.34M 3345.41M 3380.33M -388.46800M -1311.63700M
Property plant equipment - - - 8339.81M 8551.47M
Total current assets 7895.04M 7922.74M 8701.41M 8203.45M 7967.24M
Long term investments 1323.48M 1416.69M 1254.51M 773.72M 786.90M
Net tangible assets - - - -3320.40500M -3122.18700M
Short term investments 127.49M 295.63M 136.29M 169.98M 136.36M
Net receivables 3140.82M 3920.87M 3637.99M 4031.60M 3906.68M
Long term debt 5691.85M 6260.82M 6959.86M 7170.73M 6647.00M
Inventory 2140.20M 2067.92M 2179.18M 2296.21M 2038.01M
Accounts payable 737.72M 984.32M 762.07M 892.64M 818.51M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1684.13700M -328.54500M -975.16900M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 3767.38M 198.32M 223.58M 6054.00M 6263.00M
Deferred long term asset charges - - - - -
Non current assets total 23095.35M 25643.83M 25228.40M 27551.00M 26400.00M
Capital lease obligations 3490.71M 4140.70M 4145.95M 4678.76M 4749.00M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -4.02400M -84.93900M -544.22700M -71.28100M -61.57500M
Change to liabilities - - - -356.78900M -363.95500M
Total cashflows from investing activities -693.28824M -84.93900M -544.22700M -734.72500M -1196.22800M
Net borrowings 149.58M -1905.14900M -1189.79300M -1023.04500M -358.90300M
Total cash from financing activities -1431.65259M -2569.30000M -1858.52900M -1617.36000M -1024.38200M
Change to operating activities - - - 154.03M 164.20M
Net income 978.00M 740.87M 732.46M 673.40M 969.31M
Change in cash 558.68M -241.89700M 153.44M -207.86800M 400.12M
Begin period cash flow 1039.83M 1427.22M 1273.79M 1481.65M 1081.54M
End period cash flow 1598.51M 1185.33M 1427.22M 1273.79M 1481.65M
Total cash from operating activities 2679.99M 2386.14M 2628.80M 2167.38M 2489.50M
Issuance of capital stock - - - - -
Depreciation 1462.86M 1742.26M 1751.97M 1658.28M 1535.58M
Other cashflows from investing activities - 14.10M 16.14M - -
Dividends paid 422.36M 349.16M 328.62M -395.55600M -392.45500M
Change to inventory -248.56487M 107.90M -13.14000M -204.30700M -48.53000M
Change to account receivables -69.03513M -73.47700M -151.84400M -46.68200M -163.19700M
Sale purchase of stock -585.06579M 0.00000M 0.00000M 0.00000M 0.00000M
Other cashflows from financing activities -1222.55093M -314.98900M -340.11300M -218.91200M -279.53500M
Change to netincome - - - -98.09300M 32.59M
Capital expenditures 915.03M 699.36M 684.60M 723.99M 854.36M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 138.19M 444.31M 561.28M -566.00000M -354.00000M
Stock based compensation - - 32.52M - 0.00000M
Other non cash items 128.15M -468.62400M -327.27000M 1838.00M 1624.00M
Free cash flow 1764.97M 1686.79M 1944.20M 756.00M 806.00M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
FMCQF
Fresenius Medical Care AG & Co. KGaA		 - -% 45.17 14.21 9.00 0.78 0.77 0.98 5.67
HCA
HCA Healthcare, Inc.		 1.82 0.49% 376.99 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.03 0.27% 11.30 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352

Key Executives

Name Title Year Born
Ms. Helen Giza CEO, Chief Transformation Officer, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG 1968
Mr. Robert Maurice Powell Jr. Member of the Management Board of Fresenius Medical Care Management AG 1955
Dr. Franklin W. Maddux F.A.C.P. Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG 1957
Mr. William J. Valle Management Board Member for Care Delivery of Fresenius Medical Care Management AG 1960
Dr. Katarzyna Mazur-Hofsab Ph.D. Management Board Member for Care Enablement of Fresenius Medical Care Management AG 1963
Mr. Roberto Fuste Exec. Advisor for Regional Strategy 1952
Dr. Nwamaka Eneanya M.D. Head of Strategy & Operations NA
Dr. Dominik Heger Exec. VP and Head of Investor Relations, Strategic Devel. & Communications NA
Mr. Borries Von Muller Sr. VP of Global HR Employee Communications 1961
Mr. Joachim Weith Sr. VP of Corp. Communications & Gov.al Affairs NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions